Radiation-induced cranial nerve palsy: A cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1421-1427

  Kong, Lin ^a   Lu, Jiade J ^a,b   Liss, Adam L ^b,c   Hu, Chaosu ^a   Guo, Xiaomao ^a   Wu, Yongru ^a   Zhang, Youwang ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b Cancer Science Institute of Singapore   (Singapore)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Nasopharyngeal carcinoma; Radiation induced cranial nerve palsy; Radiotherapy

Indexed keywords

CONVENTIONAL FRACTIONATIONS; CRANIAL NERVE PALSY; CRANIAL NERVES; CROSS-SECTIONAL STUDY; CUMULATIVE INCIDENCE; DEFINITIVE RADIOTHERAPY; INTRA-GROUP; LONG-TERM FOLLOW-UP; MULTI VARIATE ANALYSIS; NASOPHARYNGEAL CANCER; NASOPHARYNGEAL CARCINOMA; RADIATION-INDUCED; RISK FACTORS; TOTAL RADIATION DOSE;

CHEMOTHERAPY; DERMATITIS; MULTIVARIANT ANALYSIS; MUSCULOSKELETAL SYSTEM; PATIENT MONITORING; RADIATION;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; COBALT 60; IRIDIUM 192;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CRANIAL NERVE PARALYSIS; CROSS-SECTIONAL STUDY; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIBROSIS; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RISK FACTOR;

CRANIAL NERVE DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 79952699419     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.002     Document Type: Article

References (29)

1. Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007;17:131-140. (Pubitemid 46467383)
2. Lin YS, Jen YM, Lin JC. Radiation-induced CNP in patients with nasopharyngeal carcinoma. Cancer 2002;95:404-409.
3. King AD, Leung SF, Teo P, et al. Hypoglossal nerve palsy in nasopharyngeal carcinoma. Head Neck 1999;21:614-619. (Pubitemid 29459866)
4. Chau RM, Teo PM, Kam MK, et al. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: To treat less or more in the planning organ-atrisk volume of the brainstem and spinal cord. Med Dosim 2007;32:263-270. (Pubitemid 350016880)
5. Chang JT, Lin CY, Chen TM, et al. Nasopharyngeal carcinoma with CNP: The importance of MRI for radiation therapy. Int J Radiat Oncol Biol Phys 2005;63:1354-1360. (Pubitemid 41628029)
6. Lent SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995;31:1049-1091.
7. Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiation therapy of breast cancer patients. Int J Radiat Oncol Biol Phys 2000;48:745-750.
8. Stoll BA, Andrews JT. Radiation-induced peripheral neuropathy. Br Med J 1966;1:837-843.
9. Wouter van Es H, Engelen AM, Witkamp TD, et al. Radiation-induced brachial plexopathy: MR imaging. Skeletal Radiol 1997;26:284-288. (Pubitemid 27246508)
10. Hoeller U, Bonacker M, Bajrovic A, et al. Radiation-induced plexopathyand fibrosis. Is magnetic resonance imaging the adequate diagnostic tool? StrahlentherOnkol 2004;180:650-654.
11. Teo PML, Leung FS, Chan ATC, et al. Final report of randomized trial on altered-fractionated radiation therapy in nasoparyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 2000;48:1311-1322.
12. Teo PM, Kwan WH, Yu P, et al. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiation therapy in 903 non-disseminated nasopharyngeal carcinoma patients. Clin Oncol (R Coll Radiol) 1996;8:160-166.
13. Olsen NK, Pfeiffer P, Johannsen L, et al. Radiation-induced brachial plexopathy: Neurological follow up in 161 recurrence free breast cancer patients. Int J Radiat Oncol Biol Phys 1993;26:43-49. (Pubitemid 23137886)
14. Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 2002;52:1207-1219. (Pubitemid 34296481)
15. Powell S, Cooke J, Parsons C. Radiation-induced brachial plexus injury: Follow-up of two different fractionation schedules. Radiother Oncol 1990;18:213-220. (Pubitemid 20221782)
16. Gałecki J, Hicer-Grzenkowicz J, Grudzień-Kowalska M, et al. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer - a review. Acta Oncol 2006;45:280-284. (Pubitemid 43675568)
17. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complication following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992;23:915-923.
18. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiation therapy versus radiation therapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317. (Pubitemid 28175745)
19. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiation therapy versus radiation therapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-637.
20. Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiation therapy compared with radiation therapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005;97:536-539. (Pubitemid 40590436)
21. Zhang L, Zhao C, Peng PJ, et al. Phase III study comparing standard radiation therapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results. J Clin Oncol 2005;23:8461-8468.
22. Johnson FM, Garden A, Palmer JL, et al. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. Cancer 2004;100:991-998. (Pubitemid 38222860)
23. Chan AT, Ma BB, Lo YM, et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiation therapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 2004;22:3053-3060. (Pubitemid 41103717)
24. Yeh SA, Tang Y, Lui CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 2005;62:672-679. (Pubitemid 40779753)
25. Huang SC, Chu GL. Nasopharyngeal cancer: Study II. Int J Radiat Oncol Biol Phys 1981;7:713-716. (Pubitemid 11060953)
26. Lee AWM, Law SCK, Ng SH, et al. Retrospective analysis nasopharyngeal carcinoma treated during 1976-1985: Late complications following megavoltage irradiation. Br J Radiol 1992;65:918-928.
27. Fowble BL, Solin LJ, Schultz DJ, et al. Ten-year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1991;21:269-277.
28. Bajrovic A, Rades D, Fehlauer F, et al. Is there a life-long risk of brachial plexopathy after radiation therapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol 2004;71:297-301.
29. Alsner J, Andreassen CN, Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiation therapy. Semin Radiat Oncol 2008;18:126-135. (Pubitemid 351296451)